BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2140214)

  • 1. Interferon receptors on the surface of interferon-sensitive and interferon-resistant urothelial carcinomas.
    Grups JW; Bange FC
    Urol Res; 1990; 18(2):119-22. PubMed ID: 2140214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
    Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
    Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of interferons against human bladder carcinoma cell lines in vitro.
    Grups JW; Frohmüller HG
    Urol Int; 1988; 43(5):265-8. PubMed ID: 2462294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?
    Hawkyard SJ; Jackson AM; Hawkins RA; James K; Smyth JF; Chisholm GD
    Urol Res; 1992; 20(3):229-32. PubMed ID: 1535468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
    Dunne SL; Bajzer Z; Vuk-Pavlović S
    Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: alpha, beta, and gamma.
    Morikawa K; Morikawa R; Killion JJ; Fan D; Fidler IJ
    J Natl Cancer Inst; 1990 Mar; 82(6):517-22. PubMed ID: 2138228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
    Pfeffer LM; Donner DB
    Cancer Res; 1990 May; 50(9):2654-7. PubMed ID: 2139358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Daudi cells with reduced sensitivity to interferon. IV. Characterization of clones with altered binding of human interferon alpha subspecies.
    Dron M; Tovey MG; Uzé G
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():663-9. PubMed ID: 2937878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single high affinity binding of interferon alpha 2 to receptors on human lymphoblastoid cells: internalization and inactivation of receptors.
    Faltynek CR; McCandless S; Baglioni C
    J Cell Physiol; 1985 Jun; 123(3):459-66. PubMed ID: 3157692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
    Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
    Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrostatic interactions in the cellular dynamics of the interferon-receptor complex.
    Uze G; Bandu MT; Eid P; Grütter M; Mogensen KE
    Eur J Biochem; 1988 Feb; 171(3):683-91. PubMed ID: 2964368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory effect of recombinant alpha and beta interferon on human glioma cells.
    Yung WK; Steck PA; Kelleher PJ; Moser RP; Rosenblum MG
    J Neurooncol; 1987; 5(4):323-30. PubMed ID: 2964515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells.
    Pfeffer LM; Stebbing N; Donner DB
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3249-53. PubMed ID: 2953024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha/beta genes in acute leukemia cell lines suggests selection against the IFN system.
    Colamonici OR; Domanski P; Platanias LC; Diaz MO
    Blood; 1992 Aug; 80(3):744-9. PubMed ID: 1386261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.
    Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW
    J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.
    Merlin G; Falcoff E; Aguet M
    J Gen Virol; 1985 May; 66 ( Pt 5)():1149-52. PubMed ID: 3158718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.